Connect Sign In
ARUP pairs analytical rigor with specialty expertise in immunopathology to provide reliable results, insights, and answers to complex diagnostic questions. Explore solutions with us at AMLI 2026.
ARUP Laboratories’ Infectious Disease Test Positivity Trends Dashboard now includes Cyclospora data to help clinicians and public health professionals monitor the rising cyclosporiasis outbreak.
ARUP CLARISPECT™ Multiple Myeloma MRD by Spectral Flow Cytometry characterizes neoplastic populations with greater confidence and sensitivity, while minimizing specimen volume requirements.
Discover how ARUP is advancing laboratory medicine at ADLM 2026 through research presentations, expert insights, and innovative diagnostic solutions.
Cyclosporiasis cases are on the rise. ARUP’s AI-enhanced parasite screening offers greater sensitivity to detect Cyclospora and supports outbreak response efforts.
ARUP has published the Summer 2026 edition of Magnify, which highlights applied AI in lab medicine, patient impact, and strategies to help health systems and labs thrive.
Karen Brisendine, the last of ARUP’s original 100 employees, retired after 42 years. Her career spanned multiple departments, reflecting a legacy of learning, adaptability, and service.
ARUP employees helped grant a Make-A-Wish® Utah child’s dream, transforming a lab into a supervillain’s playground and bringing joy to a family and community.
Join ARUP for the 3rd FDLC/ATLAS Course in Clinical Fungi, bringing global experts together for six days of hands-on training in fungal identification and current approaches to diagnosing and…
The study, published in the Journal of Clinical Microbiology, highlights the increased sensitivity and advantages of AI-based screening compared with manual microscopy.
Tick activity has traditionally peaked during the warmer months but that seasonal window appears to be expanding.
Newly introduced federal legislation would modernize oversight of lab-developed tests under the Clinical Laboratory Improvement Amendments but support innovation, transparency, and patient access.
